Airedale NHS Foundation Trust

Slides:



Advertisements
Similar presentations
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Advertisements

TEMPLATE DESIGN © Overview: Management Of Ovarian Cancer in Primary Care (1)Fabian Lee, Foundation Year 2. (2) Gbolahan.
Pelvic Masses & Ovarian Cancer. Differential diagnosis of pelvic masses Investigations and management Benign ovarian cysts Ovarian cancer.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Ovarian cancer….. in 15 minutes
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Ovarian Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
OVARIAN CANCER New NICE guidelines and the research behind them Journal Club 20/5/11 Natalie Brown and Matthew Parkes.
Computed tomography scan of the abdomen shows a large cystic mass in the abdomen and pelvis without solid tissue or septations (measurement: 43×20×31-cm.
TEMPLATE DESIGN © Primary Peritoneal Carcinoma found at caeserean section, value of routine abdominal examination at caeserean.
Management of ovarian cysts
Endometrial Carcinoma
Acute Oncology Dr Nicola Storey.
TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.
‘Let’s get it right - Referral for suspected Cancer’
Gynaecology MDT Coordinator
RESULTSOF UPPER GI MDT QUESTIONNAIRE Sukhbir Ubhi National Clinical Lead for Upper GI Cancer Services Collaborative 'Improvement Partnership'
Summary The National Clinical Pathway represents a pathway that is achievable now, requiring no extra resources but reliant on appropriate logistics. The.
Consultant Obstetrician & Gynaecologist
Gynaecological Oncology Patient Pathway Cecile Bergzoll Gynaecological Oncologist Wellington.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
CANCER CAUSES, REMEDIES & PREVENTION
Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist
National Clinical Pathway for suspected and confirmed lung cancer:
WiFi name: WifiLoveMCR Password: internet Join the conversation on Twitter using #DrivingChange
Overview: Breast Cancer- Surgical Treatment
Consultant Medical Oncologist
Brain Tumours – what should I know?
EOL care Closing the Gap 2b.
SWAG Cancer Alliance Update
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Dorset County Hospital Cancer of Unknown Primary (CUP) Service
Emergency Presentations in Gynaecological Oncology
Establish a Pre-consultation Process
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
Dr Amit Gupta Associate Professor Dept of Surgery
Pathway for patients with suspected Breast Cancer
Six stage journey When diagnosed with a brain tumour.
Pathway for patients with suspected Skin Cancer
Pathway for patients with suspected Upper GI (OG) Cancer
An Audit on Complex hyperplasia reporting at Derriford Hospital
Neuro Oncology Therapy Update
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Making MDTs better Steve Falk
What is the role of genetic testing in patients with ovarian cancer?
‘Improving Outcomes for people with skin tumours, including Melanoma’
Pathway for patients with suspected colorectal cancer
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Lung Cancer Pathway Dr Heather Harris - Consultant Radiologist
GEMSTONE Educational Case Summary
Worcestershire Colorectal Cancer 2ww Pathway
Dr Rajayogeswaran Dr Mike Bradley
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
Pathway for patients with suspected Breast Cancer
Neuro Oncology Therapy Update March 2019
A good MDT MDT working is considered the gold standard for cancer patient management bringing continuity of care and reducing variation in access.
Squamous cell carcinoma pathway update
Multidisciplinary Team Meeting Breast Care
A good MDT MDT working is considered the gold standard for cancer patient management bringing continuity of care and reducing variation in access.
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Calderdale and Huddersfield NHS Foundation Trust
York Teaching Hospitals NHS Trust
Standardised follow-up
GP access to body CT for suspected malignancy
Mid-Yorkshire Hospitals
Presentation transcript:

Airedale NHS Foundation Trust Gynaecology MDT Claire Parkinson Macmillan Gynaecology Nurse Specialist The Cancer Alliance is part of West Yorkshire and Harrogate Health and Care Partnership - www.canceralliance.wyhpartnership.co.uk Twitter: @WYHpartnership or @profseanduffy

Approach used Proforma created to standardise information to enable optimal MDT discussions Flow charts of patients’ pathways developed with a SOP for straightforward patients and patients who can be streamlined outside of the MDT

Issues Discussion of non cancer patients No clear questions Delays in pathway waiting for MDT decisions Relevant information not known (Performance status, co-morbidities, patients’ wishes & understanding)

Challenges Time All to be involved Lack of IT skills Embedding the new proforma Making all aware of changes

Outcomes with Proforma Time saved preparing for MDT Optimal MDT discussions Knowing what the question is which needs addressing Saving time in the MDT

Outcomes expected with pathways & SOP Reduction in frequency of patients being discussed Shortening of the patients’ pathway Education of staff of usual investigations & management plan None cancer patients being discussed outside the MDT

Flow chart for management of patients with a suspected or diagnosed endometrial cancer outside the MDT meeting Suspicion of cancer unable to gain access to cavity Atypical hyperplasia Severe atypical cells and or suspicion of cancer Grade 1 or 2 adenocarcinoma of the endometrium High grade Endometrial cancer Discussion with patient re options – Progesterone intrauterine or oral Discussion with patient re most appropriate treatment - hysterectomy Organise urgent MRI & ensure recent U&E’s Organise urgent CT scan Abdo / pelvic & chest ensure U&E’s Discussion with patient re options surgery / monitoring Meet patient & list for local surgery Inform patient Discussion at local MDT Discussion at Local MDT Discuss with central MDT Discuss at local MDT if IB discuss centrally List for Hysterectomy& BSO or request MRI Scan List for surgery or commence other treatment Ensure dated at Leeds & OPD & pre-op booked Commence treatment Register centrally post op All patients on fast track pathway or who have been upgraded should have treatment before day 62

Meet patient & discuss likely plan Flow chart for management of patients with a suspicion of ovarian / Primary peritoneal / tubal cancer outside of MDT meetings Complex cyst with septations Normal CA 125 Risk of Malignancy Index (RMI) < 250 Simple cyst normal CA 125 or Dermoid cyst Complex cyst raised CA 125 RMI >250 Ascites and or omental / peritoneal disease on scan Request an urgent CT scan Repeat CA 125 & request CEA & CA 19.9 Tumour markers (CA 125 CEA CA 19.9) Discuss with radiologists if biopsy possible. Request & organise biopsy There is no need to refer to the MDT. Discuss management with radiologists and or consultant Request an urgent MRI scan. If high concerns of malignancy discuss with radiology Repeat CA 125 (to ensure not rising) request CEA & CA 19.9 Meet patient & explain possible plan Meet patient & discuss likely plan Discuss local & central MDT Meet with patient add to waiting list for surgery Discuss local & central MDT Ensure OPD with surgeon at Leeds or Oncologist Discuss local MDT & central if suspicious of malignancy Organise OPD with Oncologist or Surgeon at Leeds All patients on fast track pathway or who have been upgraded should have treatment before day 62

Flow chart for management of patients with a diagnosis cervical cancer outside the MDT meeting Stage 1A1 completely excised by loop excision Squamous cell carcinoma Any Adenocarcinoma Any cervical cancer greater than 1A1 from LLETZ or cone Request MRI scan ensure U&E’s have been done Organise MRI if disseminated disease suspected CT may also be required Clinic appointment to inform patient Clinic appointment to inform patient Clinic appointment to inform patient Annual cervical cytology test for 10 years Addition to central MDT Addition to Central MDT Book OPD to see relevant consultant – surgery / radiotherapy / chemotherapy PET scan usually organised by Leeds – Inform patient Discuss at local MDT & add to central for registration / information only Book OPD to see relevant consultant – surgery / radiotherapy / chemotherapy

Flow chart for management of patients with a suspected or diagnosis of vulval cancer outside the MDT meeting Suspicion of malignancy & unable to biopsy in OPD Any stage or grade of cancer of the vulva found Patient has an obvious lesion which is less than 2cm & is symptomatic with other comorbidities & not fit for extensive treatment If clinically thought to have nodal involvement or more extensive disease organise appropriate imaging MRI / CT discuss with radiologist if unsure To organise a biopsy in theatre under LA or GA Consider excision of entire lesion. Consider discussion with core member of central MDT. A photograph prior to surgery can be helpful. If no cancer found & no concerns with specimen obtained no need to discuss at MDT Organise OPD to be informed of results Organise OPD to inform patient of diagnosis Referral & discussion at the central MDT Discuss centrally If concerns discuss with core member of MDT & add to MDT if felt appropriate Ensure OPD for appropriate consultant made surgeon . Clinical oncologist or medical oncologist Dependent on outcome of MDT organise appropriate OPD

Flow chart of the management of patients with a suspicion of or diagnosis of vaginal cancer Suspicion of a vaginal cancer on examination Confirmed cancer following biopsy Organise further imaging usually MRI but if disease thought to be more extensive than pelvis both MRI & CT may be required – Ensure U&E’s available If unable to take biopsy in OPD organise GA / theatre urgently Organise OPD to inform patient of diagnosis If benign no need to discuss at MDT unless you remain suspicious that this is a cancer Add to central MDT once confirmed cancer found Organise OPD with appropriate consultant – Surgeon Leeds / Clinical Oncologist / Medical Oncologist

Any questions?